Yeast strains for reducing contamination by lactic acid bacteria
20230183302 · 2023-06-15
Assignee
Inventors
Cpc classification
Y02E50/10
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C07K14/705
CHEMISTRY; METALLURGY
International classification
Abstract
Described herein is a yeast strain wherein activity of one or more membrane transporters of the DHA1 family is reduced relative to a wild type strain or to a parental strain from which it is derived.
Claims
1. A yeast strain wherein activity of one or more membrane transporters of the DHA1 family is reduced relative to a wild type strain or to a parental strain from which it is derived.
2. The yeast strain according to claim 1, wherein one or more nucleotide sequences encoding the one or more membrane transporters of the DHA1 family are deleted or inactivated, or wherein expression of said one or more nucleotide sequences is downregulated, preferably inducibly downregulated.
3. The yeast strain according to claim 1, wherein the one or more membrane transporters of the DHA1 family are selected from the group consisting of AQR1, QDR1, QDR2, QDR3, TPO1, TPO2, TPO3, TPO4, FLR1, YHK8, DTR1, HOL1 and/or homologues thereof.
4. The yeast strain according to claim 1, wherein the one or more membrane transporters of the DHA1 family are encoded by a nucleotide sequence comprising, consisting essentially of or consisting of a sequence having at least 60% sequence identity with any of the nucleotide sequences set forth in SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22 and 24; or comprise, consist essentially of or consist of an amino acid sequence having at least 60% identity or similarity with any of the amino acid sequences set forth in SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21 and 23.
5. The yeast strain according to claim 1, having reduced activity of at least two, at least three, at least four, at least five, at least six, or at least seven transporters of the DHA1 family relative to a wild type strain or to a parental strain from which it is derived.
6. The yeast strain according to claim 1, wherein the one or more membrane transporters comprise: AQR1, QDR2 and QDR3 or homologues thereof; QDR1, QDR2 and QDR3 or homologues thereof; AQR1, QDR2, QDR1 and TPO4 or homologues thereof; or AQR1, QDR3, QDR2, QDR1, DTR1, HOL1 and TPO1, or homologues thereof.
7. The yeast strain according to claim 1, wherein the yeast is a Saccharomyces species, preferably Saccharomyces cerevisiae.
8. A composition comprising, consisting essentially of, or consisting of a yeast strain according to claim 1; and optionally one or more formulation excipients, preferably wherein the composition is a dry yeast composition or an instant yeast composition.
9. A method for the production of yeast cells, comprising culturing a yeast strain as defined in claim 1 in a suitable culture medium.
10. A method for producing a fermentation product, comprising: culturing a yeast strain as defined in claim 1 on a fermentable substrate; and optionally, recovering the fermentation product.
11. The method according to claim 10, wherein the fermentation substrate comprises, consists essentially of or consists of an unrefined or low-processed source of sugars.
12. The method according to claim 10, wherein the fermentation product is an alcohol, preferably a lower alkyl alcohol such as ethanol, propanol or butanol, more preferably ethanol.
13. A method for the production of a product of interest, comprising: a) optionally, transforming a yeast cell according to claim 1 with a vector encoding the product of interest or encoding one or more enzymes capable of producing the product of interest; b) culturing the yeast cell in a culture medium to produce the product of interest; and c) optionally, isolating the product of interest from the yeast cell or culture medium.
14. A method for eliminating, reducing or preventing contamination of lactic acid bacteria in yeast cultures, the method comprising culturing a yeast strain as defined in claim 1.
15. The method according to claim 14, wherein the lactic acid bacteria comprise a Lactobacillus species.
Description
DESCRIPTION OF THE FIGURES
[0150]
[0151]
[0152]
[0153]
EXAMPLES
Example 1: Reduced Expression of Four DHA1-Family Genes in Yeast Causes Reduced Amino Acid Excretion and Reduced Propensity to Support Growth of Cocultivated Lactic Acid Bacteria (LAB)
[0154] Yeast S. cerevisiae strains 23344c (wild-type, wt), GK097 (aqr1Δ qdr2Δ qdr1Δ tpo4Δ) were cocultivated with Lactobacillus fermentum (auxotroph for several amino acids) on a MES-buffered minimal glucose medium (169) devoid of amino acids and containing NH.sub.4.sup.+ as sole nitrogen source. The number of cells per ml of culture was measured just after inoculation (time 0) and 64 h after growth in order to calculate the LAB to yeast cell expansion ratios. As can be seen in
Example 2: Reduced Expression of Seven DHA1-Family Genes in Yeast Causes Reduced Amino Acid Excretion and Reduced Propensity to Support Growth of Cocultivated Lactic Acid Bacteria (LAB)
[0155] Yeast S. cerevisiae strains 23344c (wild-type, wt) and FV1170 (aqr1Δ qdr3Δ qdr2Δ qdr1Δ dtr1Δ hol1Δ tpo1Δ) were cocultivated with Lactobacillus fermentum (auxotroph for several amino acids) on a MES-buffered minimal glucose medium (169) devoid of amino acids and containing NH.sub.4.sup.+ as sole nitrogen source. The number of cells per ml of culture was measured just after inoculation (time 0) and 64 h after growth in order to calculate the LAB to yeast cell expansion ratios. As can be seen in
Example 3. Reduced Expression of Three DHA1-Family Genes in Yeast Causes Reduced Amino Acid Excretion and Reduced Propensity to Support Growth of Cocultivated Lactic Acid Bacteria
[0156] (A). The MES-buffered minimal glucose medium (169) containing NH.sub.4.sup.+ as sole nitrogen source, and to which amino acids have been added or not (as amino acid dropout mixture), was inoculated with Lactobacillus fermentum (auxotroph for several amino acids). Samples of the cultures were withdrawn just after inoculation (time 0) and after 48 hours of incubation at 29° C. Cell densities were measured by counting the number of colony-forming units per ml of culture (CFU/ml). The results presented in
Example 4. Reduced Expression of Three DHA1-Family Genes in an Industrial Yeast Strain Causes Reduced Amino Acid Excretion and Reduced Propensity to Support Growth of Cocultivated Lactic Acid Bacteria
[0157] Industrial yeast S. cerevisiae strain Ethanol Red (wild-type, w-t) and the derivative strain CF171 (qdr1Δ qdr2Δ qdr3Δ) were cocultivated with Lactobacillus fermentum on a MES-buffered minimal glucose medium (169) devoid of amino acids and containing NH.sub.4.sup.+ as sole nitrogen source. The number of colony forming units per ml of culture (CFU/ml) was measured just after inoculation (time 0) and 48 h after growth in order to calculate the L. fermentum to yeast cell propagation ratios. As can be seen in
[0158] Composition of the 169 Medium Used for Cocultures of S. cerevisiae and L. fermentum
[0159] The medium is prepared by mixing basal 169 medium with samples of trace metals (×1000) and vitamins (×100) solutions. One liter of basal 169 medium contains: 0.7 g MgSO.sub.4.7 H.sub.2O, 1 g KH.sub.2PO.sub.4, 0.4 g CaCl.sub.2.Math.2H.sub.2O, 0.5 g NaCl, 5 g (NH.sub.4).sub.2SO.sub.4, 19.5 g 2-(N-morpholino)ethanesulfonic acid (MES). This medium was adjusted to pH 6.1 with NaOH 10M and sterilized. 100 ml of vitamin solution (×100) contains 15 μg D-biotin, 10 mg thiamine.Math.HCl, 100 mg inositol, 20 mg calcium D-panthothenate, 10 mg pyridoxin.Math.HCl, 5.6 mg folic acid, 9 mg nicotinic acid, 0.5 mg 4-aminobenzoic acid, 9 mg riboflavin, and 150 mg glutathione. 100 ml of trace metals solution (×1000) contains 10 mg H.sub.3BO.sub.4, 1 mg CuSO.sub.4.Math.5H.sub.2O, 2 mg KI, 4 mg Na.sub.2MoO.sub.4.Math.2H.sub.2O, 14 mg ZnSO.sub.4.Math.7H.sub.2O, 10 g citric acid.Math.H.sub.2O, 400 mg MnSO.sub.4.Math.H.sub.2O, 5 g FeCl.sub.3.Math.6H.sub.2O, and 190 mg CoCl.sub.2.Math.H.sub.2O.
[0160] Methods for Isolating Yeast Mutants.
[0161] The genes in the above-described yeast mutants were deleted by either the classical PCR-based replacement with antibiotic resistance genes (Wach et al., 1994) or a recently described CRISPR/Cas9-based method (Mans et al., 2018).
REFERENCES
[0162] Beckner, M., Ivey, M. L., & Phister, T. G. (2011). Microbial contamination of fuel ethanol fermentations. Letters in Applied Microbiology, 53(4), 387-394. http://doi.org/10.1111/j.1472-765X.2011.03124.x [0163] Challinor, S. W., & Rose, A. H. (1954). Interrelationships between a yeast and a bacterium when growing together in defined medium. Nature, 174(4436), 877-878. http://doi.org/10.1038/174877b0 [0164] Grenson, M. (1973). Specificity and regulation of the uptake and retention of amino acids and pyrimidines in yeast. In Z. Vanek, Z. Hostalek, & J. Cudlin (Eds.), Genetics of industrial microorganisms (pp. 179-193). Prague: New York, Elsevier Pub. Co. [0165] Mans, R., Wijsman, M., Daran-Lapujade, P., and Daran, J.-M. (2018). A protocol for introduction of multiple genetic modifications in Saccharomyces cerevisiae using CRISPR/Cas9. FEMS Yeast Res. 18, 3329. [0166] Narendranath, N. V., Hynes, S. H., Thomas, K. C., & Ingledew, W. M. (1997). Effects of lactobacilli on yeast-catalyzed ethanol fermentations. Applied and Environmental Microbiology, 63(11), [0167] Ponomarova, O., Gabrielli, N., Sévin, D. C., Mülleder, M., Zirngibl, K., Bulyha, K., et al. (2017). Yeast Creates a Niche for Symbiotic Lactic Acid Bacteria through Nitrogen Overflow. Cell Systems. http://doi.org/10.1016/j.cels.2017.09.002 [0168] Skinner, K. A., & Leathers, T. D. (2004). Bacterial contaminants of fuel ethanol production. Journal of Industrial Microbiology & Biotechnology, 31(9), 401-408. http://doi.org/10.1007/s10295-004-0159-0 [0169] Velasco, I., Tenreiro, S., Calderon, I. L., & André, B. (2004). Saccharomyces cerevisiae Aqr1 is an internal-membrane transporter involved in excretion of amino acids. Eukaryotic Cell, 3(6), 1492-1503. http://doi.org/10.1128/EC.3.6.1492-1503.2004 [0170] Wach, A., Brachat, A., Pohlmann, R., and Philippsen, P. (1994). New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 10, 1793-1808.